RESUMO
Diisocyanate-induced asthma is difficult to diagnose since the immunopathological mechanisms and exposure determinants at the workplace are not well defined. The aim of this study was to evaluate the non-invasive methods of nasal lavage fluid (NALF) and induced sputum (IS) to enhance the diagnostic efficiency. Sixty-three diisocyanate-exposed workers with work-related shortness of breath underwent a standardized 4-steps-1-day-whole body exposure test with diisocyanates used at work up to 30 ppb. NALF and IS were collected before, 0.5, and 19 h after the end of exposure. Cellular composition and soluble inflammatory biomarkers were studied in the samples. In addition, ten controls with bronchial hyperresponsiveness, but without prior occupational diisocyanate exposure, were also examined. Twelve out of the 63 subjects (19 %) showed a significant asthmatic reaction (pulmonary responders) after challenge (FEV1 decrease >20 %). NALF samples did not demonstrate significant effects either on cellular composition or on mediator concentrations in the responders, non-responders, or controls at any time point. In contrast, in the IS samples of the pulmonary responders collected 19 h after challenge, the percentage of eosinophils was higher (p = 0.001) compared with baseline before challenge. Eosinophils were also increased 30 min and 19 h after challenge in IS samples of the responders compared with the non-responders or controls. In addition, 19 h after challenge the eosinophilic cationic protein (ECP) concentration was significantly higher in the responders than non-responders (p < 0.04) or controls (p < 0.002). In conclusion, positive asthmatic reactions to diisocyanates are accompanied by an influx of eosinophils into lower airways. Analysis of induced sputum should be implemented in the diagnostic procedure of diisocyanate-related airway diseases.
Assuntos
Asma/induzido quimicamente , Asma/diagnóstico , Testes de Provocação Brônquica/métodos , Isocianatos/efeitos adversos , Doenças Profissionais/induzido quimicamente , Doenças Profissionais/diagnóstico , Adulto , Biomarcadores/metabolismo , Brônquios/efeitos dos fármacos , Hiper-Reatividade Brônquica/imunologia , Proteína Catiônica de Eosinófilo/sangue , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Líquido da Lavagem Nasal , Exposição Ocupacional , Fumar , Fatores de TempoRESUMO
Este caso clínico hace referencia a un tumor del tejido blando, el fibrosarcoma. Si bien este tipo de tumor no es muy frecuente en la población, el fibrosarcoma es uno de los más comunes dentro de este grupo. Debido a esto hemos querido complementarlo con una revisión bibliográfica que incluye sus características generales, los hallazgos histopatológicos, el diagnóstico y tratamiento propuesto en la literatura.
Assuntos
Humanos , Masculino , Adolescente , Fibrossarcoma/cirurgia , Fibrossarcoma/patologia , Neoplasias de Cabeça e Pescoço/cirurgia , Neoplasias de Cabeça e Pescoço/patologia , Fibrossarcoma/diagnóstico , Neoplasias de Cabeça e Pescoço/diagnóstico , Prognóstico , Próteses e Implantes , Resultado do Tratamento , Sinais e Sintomas , Intervalo Livre de Doença , Titânio/uso terapêuticoRESUMO
Experimental aspiration of water soluble contrast agents was performed on rats via transoral endotracheal injection. Iopamidol, iohexol and diatrizoate were the contrast agents tested. One group of rats received normal saline as a control. Adjusted lung weights were measured at 2 and 24 hours post aspiration. Radiographs were taken at 2 and 24 hours post aspiration and scored for abnormal pulmonary air space density. Diatrizoate alone demonstrated an increase in adjusted lung weights. Diatrizoate, iopamidol and iohexol showed abnormal pulmonary air space disease on radiographs at 2 hours but not at 24 hours. Histopathologic examination of rat lungs following aspiration of all three contrasts showed pulmonary vascular congestion and perivascular edema. Iopamidol showed evidence of acute cellular inflammation. Iohexol provoked a pulmonary alveolar macrophage response.
Assuntos
Inalação , Iohexol/toxicidade , Iopamidol/toxicidade , Pulmão/efeitos dos fármacos , Respiração , Animais , Diatrizoato/administração & dosagem , Diatrizoato/toxicidade , Iohexol/administração & dosagem , Iopamidol/administração & dosagem , Pulmão/patologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Transtornos Respiratórios/induzido quimicamente , Transtornos Respiratórios/patologiaRESUMO
The effect on urinary electrolyte excretion, renin release and plasma norepinephrine of single oral doses of 400 mg etozolin (E) and of 40 mg furosemide (F) were studied in hypertensive patients with normal (n = 6) and impaired kidney function (n = 6). E caused a marked saluresis up to 24 hours, showing its long duration of action. F, however, displayed a brief, brisk peak diuresis, followed by a rebound from the 4th to the 24th hours. The brisk peak diuresis induced by F was associated with pronounced release of renin, almost twice that induced by E. In chronic renal failure the renin release in relation to the magnitude of the diuresis was increased, i.e. the sensitivity of these patients to changes in water homeostasis was increased. E and F stimulated the sympathetic system to roughly the same extent. Patients with essential hypertension had higher plasma levels of norepinephrine than hypertensive patients with chronic renal failure. In addition, hypertensive patients with normal renal function (n = 4) and varying degrees of renal impairment (n = 11) were also given 400 mg daily for 2 weeks. Effects on blood pressure and electrolyte homeostasis were monitored, as well as the plasma kinetics of metabolite I, ozolinone. At the end of the 2 week treatment E had significantly lowered systolic (-12 mm Hg) and diastolic (-9 mm Hg) blood pressure, and had produced a significant loss of body weight, without altering plasma electrolytes or blood chemistry. There was no accumulation of the effective metabolite ozolinone under conditions of severe impairment of kidney function.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Anti-Hipertensivos/farmacologia , Diuréticos/metabolismo , Hipertensão/metabolismo , Falência Renal Crônica/metabolismo , Tiazóis/metabolismo , Tiazóis/farmacologia , Adulto , Feminino , Furosemida/farmacologia , Humanos , Cinética , Masculino , Pessoa de Meia-Idade , Norepinefrina/metabolismo , Renina/metabolismoRESUMO
Percutaneous transluminal angioplasty in renal artery obstructions was performed in 10 cases. In 7 patients the hypertension was successfully treated and in one patient renal function could be restored. The procedure can be applied in atherosclerotic and fibromuscular stenoses as well as in stenosis of kidney grafts. In our opinion catheter dilatation should be prefered to vascular surgery, because it is efficient and inexpensive and has a low risk. Operation should be reserved to cases untreatable with angioplasty.
Assuntos
Cateterismo , Hipertensão Renal/terapia , Hipertensão Renovascular/terapia , Adulto , Cateterismo/métodos , Dilatação/instrumentação , Humanos , Pessoa de Meia-Idade , Obstrução da Artéria Renal/terapiaRESUMO
Increasing concentrations of angiotensin I and different perfusion rates were used to study the conversion of angiotensin I in guinea-pig and rat lungs. Even the highest concentration used (32.0 muM), which is a thousand times higher than that which occurs in vivo, was unable to saturate the converting system indicating the enormous capacity of this system. SQ 20881 proved to be a reversible inhibitor of the converting system. Its effect on the angiotensin I conversion was greater in guinea-pig lungs than in rat lungs (ID50 was 40.0 nM in guinea-pig lung and above 360.0 nM in rat lungs at a substrate concentration of 38.6 nM).
Assuntos
Angiotensina II/metabolismo , Pulmão/metabolismo , Angiotensina II/biossíntese , Angiotensina II/imunologia , Inibidores da Enzima Conversora de Angiotensina , Animais , Especificidade de Anticorpos , Ligação Competitiva , Feminino , Cobaias , Técnicas In Vitro , Cinética , Masculino , Perfusão , Radioimunoensaio , Ratos , Teprotida/farmacologiaRESUMO
Prostaglandins (Pgs), slow-reacting substance of anaphylaxis (SRS-A), and histamine were released from anaphylactic isolated perfused guinea pig hearts. Pgs were to the greatest part of the F2alpha-type. PgE2 was found in traces only. Neither PgA2, nor the metabolites 13,14-dihydro-15-keto-PgF2alpha and 13,14-dihydro-15-keto-PgE2 were detected in the perfusates. Isoproterenol reduced the PgF2alpha output significantly. This effect was increased by the addition of theophylline. Propranolol did not reverse the effect of isoproterenol, but in a high concentration (5 mug/ml) reduced the PgF2alpha output for its own. Indomethacin completely abolished the anaphylactic prostaglandin release. The histamine liberation was significantly decreased only by the combination of isoproterenol and theophylline, and also by a high concentration of propranolol (5 mug/ml). In contrast to the Pg release, the anaphylactic SRS-A and histamine liberation was not abolished by indomethacin, but rather increased. The results are discussed in view of the possible role of the released substances in the functional events of cardiac anaphylaxis.